PhiloGene, Inc. Announces that VEGFb(TM) has been Granted Orphan Drug Designation by the FDA for the Treatment of Advanced Melanoma
... VEGFb. "This is a significant milestone and accomplishment for PhiloGene," commented Miriam Mangelus, PhD MBA, CEO of PhiloGene. "We are very pleased to receive this support from the FDA, ...
More...
... VEGFb. "This is a significant milestone and accomplishment for PhiloGene," commented Miriam Mangelus, PhD MBA, CEO of PhiloGene. "We are very pleased to receive this support from the FDA, ...
More...